menu

Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence

close
1.00 credits
60 minutes

CME/CE Broadcast Replay

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
1.00 credits
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    Nontuberculous mycobacterial (NTM) lung disease is a chronic, progressive illness fraught with long treatments and severe side effects. The majority of NTM patients who have completed treatment can get it again. Research is emerging that may impact best practices in managing and treating patients with NTM along with new American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. In this program, learn practical tools to diagnose, treat, and manage NTM. 

  • Disclosure of Conflicts of Interest

    In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose any relevant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

    All CME educational activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

    Faculty Disclosures
    Charles Daley, MD discloses he is on an advisory board for Insmed, Johnson & Johnson, Spero Pharmaceuticals, Paratek, Meiji, Matinas Biopharma, Cipla, and AN2 Therapeutics. He receives research grants from Insmed, Spero, and Beyond Air and is on a data monitoring committee for Otsuka and Lilly.

    Shannon Kasperbauer, MD discloses she is on an advisory board for Insmed and AN2 Therapeutics and a speaker for Paratek.

    Planners and Reviewers Disclosures
    Meghan Brenner, MA has no financial relationships to disclose.
    Jared J. Eddy, MD has no financial relationships to disclose.
    Andrea Harshman, MHA, CHCP, CMP-HC has no financial relationships to disclose.
    Gwen Huitt, MD, MS has no financial relationships to disclose.
    Lauren Rieck has no financial relationships to disclose.
    The patient in the video has no financial relationships to disclose.

  • Target Audience

    This activity is intended for pulmonologists, infectious disease physicians, and internal medicine physicians.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    1. Apply strategies to reduce time to diagnosis and initiation of evidence-based treatment of NTM-LD
    2. Use a patient-centered approach for communications related to diagnosis and development of individualized treatment plans in NTM-LD
    3. Integrate strategies to manage adverse events and improve adherence to promote the completion of treatment regimens and improved patient outcomes in NTM-LD
  • Accreditation and Credit Designation Statements

    National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    National Jewish Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Provided by National Jewish Health.

    ReachMD Healthcare Image

  • Commercial Support

    Supported by an Educational Grant from Insmed.

  • Tests/Evaluation

    To obtain credit, a score of 2 out of 3 or better on the post-test is required. There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

    1. Read the learning objectives and disclosures
    2. Study the educational activity
    3. Complete the post-test and the evaluation form

    If you successfully complete the post-test (score of 2 out of 3 or higher), your certificate will be made available immediately. If you have any question relating to the accreditation of this activity, please contact: proed@njhealth.org.

  • Disclosure of Unlabeled Use

    The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

    No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.

    Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

  • Disclaimer

    National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

    By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

    Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

  • Privacy Policy

    https://www.nationaljewish.org/education-training/pro-ed/privacy-policy-and-practices

    The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME). 

    We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming.

    If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Nontuberculous mycobacterial (NTM) lung disease is a chronic, progressive illness fraught with long treatments and severe side effects. The majority of NTM patients who have completed treatment can get it again. Research is emerging that may impact best practices in managing and treating patients with NTM along with new American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. In this program, learn practical tools to diagnose, treat, and manage NTM. 

  • Disclosure of Conflicts of Interest

    In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose any relevant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

    All CME educational activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

    Faculty Disclosures
    Charles Daley, MD discloses he is on an advisory board for Insmed, Johnson & Johnson, Spero Pharmaceuticals, Paratek, Meiji, Matinas Biopharma, Cipla, and AN2 Therapeutics. He receives research grants from Insmed, Spero, and Beyond Air and is on a data monitoring committee for Otsuka and Lilly.

    Shannon Kasperbauer, MD discloses she is on an advisory board for Insmed and AN2 Therapeutics and a speaker for Paratek.

    Planners and Reviewers Disclosures
    Meghan Brenner, MA has no financial relationships to disclose.
    Jared J. Eddy, MD has no financial relationships to disclose.
    Andrea Harshman, MHA, CHCP, CMP-HC has no financial relationships to disclose.
    Gwen Huitt, MD, MS has no financial relationships to disclose.
    Lauren Rieck has no financial relationships to disclose.
    The patient in the video has no financial relationships to disclose.

  • Target Audience

    This activity is intended for pulmonologists, infectious disease physicians, and internal medicine physicians.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    1. Apply strategies to reduce time to diagnosis and initiation of evidence-based treatment of NTM-LD
    2. Use a patient-centered approach for communications related to diagnosis and development of individualized treatment plans in NTM-LD
    3. Integrate strategies to manage adverse events and improve adherence to promote the completion of treatment regimens and improved patient outcomes in NTM-LD
  • Accreditation and Credit Designation Statements

    National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    National Jewish Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Provided by National Jewish Health.

    ReachMD Healthcare Image

  • Commercial Support

    Supported by an Educational Grant from Insmed.

  • Tests/Evaluation

    To obtain credit, a score of 2 out of 3 or better on the post-test is required. There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

    1. Read the learning objectives and disclosures
    2. Study the educational activity
    3. Complete the post-test and the evaluation form

    If you successfully complete the post-test (score of 2 out of 3 or higher), your certificate will be made available immediately. If you have any question relating to the accreditation of this activity, please contact: proed@njhealth.org.

  • Disclosure of Unlabeled Use

    The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

    No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.

    Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

  • Disclaimer

    National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

    By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

    Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

  • Privacy Policy

    https://www.nationaljewish.org/education-training/pro-ed/privacy-policy-and-practices

    The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME). 

    We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming.

    If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule24 Oct 2021
Webpack App